切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2024, Vol. 19 ›› Issue (06) : 546 -549. doi: 10.3877/cma.j.issn.1673-9450.2024.06.017

综述

肠道菌群与椎间盘退行性变相关性的研究进展
戴睿1, 张亮1,2,(), 陈浏阳1, 张永博3, 吴丕根1, 孙华1, 杨盛2, 孟博3   
  1. 1.225001 扬州大学附属苏北人民医院骨科
    2.225001扬州,苏北人民医院骨科
    3.225001 大连医科大学扬州临床医学院骨科
  • 收稿日期:2024-04-26 出版日期:2024-12-01
  • 通信作者: 张亮

Research progress on the correlation between intestinal flora and intervertebral disc degeneration

Rui Dai1, Liang Zhang1,2,(), Liuyang Chen1, Yongbo Zhang2, Pigen Wu1, Hua Sun1, Sheng Yang3, Bo Meng2   

  1. 1.Department of Orthopedics,Northern Jiangsu People's Hospital Affiliated to Yangzhou University,Yangzhou 225001,China
    2.Department of Orthopedics,the Yangzhou School of Clinical Medicine of Dalian Medical University,Yangzhou 225001,China
    3.Department of Orthopedics, Northern Jiangsu People's Hospital,Yangzhou 225001,China
  • Received:2024-04-26 Published:2024-12-01
  • Corresponding author: Liang Zhang
引用本文:

戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.

Rui Dai, Liang Zhang, Liuyang Chen, Yongbo Zhang, Pigen Wu, Hua Sun, Sheng Yang, Bo Meng. Research progress on the correlation between intestinal flora and intervertebral disc degeneration[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(06): 546-549.

腰痛是一种常见的临床症状,其病因较为复杂。 椎间盘退行性变是导致腰痛的主要原因之一,但其发病机制尚不明确。 肠道菌群是消化道的重要组成部分,可通过一系列代谢物和分子来影响宿主健康,但肠道菌群是否参与椎间盘退行性变尚无定论。 本文通过总结相关文献,对肠道菌群与椎间盘退行性变的相关性以及肠道菌群参与椎间盘退行性变的机制进行综述。

Low back pain is a common clinical symptom with complex etiology.Intervertebral disc degeneration is considered to be one of the main causes of low back pain,but its mechanism is not well understood.Gut microbiota is an important part of the digestive tract which can affect host health through a range of metabolites and molecules,but whether gut microbiota is involved in disc degeneration has not been elucidated.Based on the summary of relevant literature, the correlation betweenintestinal flora and intervertebral disc degeneration and the mechanism of intestinal flora participating in intervertebral disc degeneration are summarized as follows.

[1]
Hoy D,Brooks P,Blyth F,et al.The epidemiology of low back pain[J].Best Pract Res Clin Rheumatol,2010,24(6):769-781.
[2]
Cheung KM,Karppinen J,Chan D,et al.Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals [J].Spine (Phila Pa 1976),2009,34(9): 934-940.
[3]
Ma Q,Li Y,Li P,et al.Research progress in the relationship between type 2 diabetes mellitus and intestinal flora[J].Biomed Pharmacother,2019,117: 109138.
[4]
Franzosa EA,Sirota-Madi A,Avila-Pacheco J,et al.Gut microbiome structure and metabolic activity in inflammatory bowel disease [J].Nat Microbiol,2019,4(2):293-305.
[5]
Chen ML,Yi L,Zhang Y,et al.Resveratrol attenuates trimethylaminen-oxide(tmao)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota [J].mBio,2016,7(2): e02210-e02215.
[6]
Kim MS,Kim Y,Choi H,et al.Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model [J].Gut,2020,69(2): 283-294.
[7]
Hao ML,Wang GY,Zuo XQ,et al.Gut microbiota: an overlooked factor that plays a significant role in osteoporosis [J].J Int Med Res,2019,47(9): 4095-4103.
[8]
Rajasekaran S, Soundararajan DCR,Tangavel C,et al.Human intervertebral discs harbour a unique microbiome and dysbiosis determines health and disease[J].Eur Spine J,2020,29(7):1621-1640.
[9]
Li W, Lai K, Chopra N, et al.Gut-disc axis: a cause of intervertebral disc degeneration and low back pain? [J].Eur Spine J,2022,31(4): 917-925.
[10]
Verdu EF,Galipeau HJ,Jabri B.Novel players in coeliac disease pathogenesis:role of the gut microbiota[J].Nat Rev Gastroenterol Hepatol,2015,12(9):497-506.
[11]
Yurube T, Ito M, Kakiuchi Y, et al.Autophagy and mTOR signaling during intervertebral disc aging and degeneration [J].JOR Spine,2020,3(1): e1082.
[12]
Fournier DE,Kiser PK,Shoemaker JK,et al.Vascularization of the human intervertebral disc: a scoping review [J].JOR Spine,2020,3(4): e1123.
[13]
Rajasekaran S,Tangavel C,Vasudevan G,et al.Bacteria in human lumbar discs-subclinical infection or contamination? Metabolomic evidence for colonization,multiplication,and cell-cell cross-talk of bacteria [J].Spine J,2023,23(1):163-177.
[14]
Yao B,Cai Y,Wang W,et al.The effect of gut microbiota on the progression of intervertebral disc degeneration [J].Orthop Surg,2023,15(3):858-867.
[15]
Katan MB.Apolipoprotein E isoforms,serum cholesterol,and cancer[J].Lancet (London,England),1986,1(8479):507-508.
[16]
Emdin CA,Khera AV,Kathiresan S.Mendelian randomization[J].JAMA,2017,318(19): 1925-1926.
[17]
Su M,Tang Y,Kong W,et al.Genetically supported causality between gut microbiota,gut metabolites and low back pain:a twosample Mendelian randomization study[J].Front Microbiol,2023,14: 1157451.
[18]
Geng Z,Wang J,Chen G,et al.Gut microbiota and intervertebral disc degeneration:a bidirectional two-sample Mendelian randomization study[J].J Orthop Surg Res,2023,18(1): 601.
[19]
Zheng D,Wu Z, Li L, et al.Genetic analysis of the causal relationship between gut microbiota and intervertebral disc degeneration: a two-sample Mendelian randomized study[J].Eur Spine J,2024,33(5):1986-1998.
[20]
Gruber HE,Hoelscher GL,Ingram JA,et al.IGF-1 rescues human intervertebral annulus cells from in vitro stress-induced premature senescence[J].Growth Factors,2008,26(4): 220-225.
[21]
Detamore MS, Athanasiou KA.Effects of growth factors on temporomandibular joint disc cells[J].Arch Oral Biol,2004,49(7): 577-583.
[22]
Huang CY,Travascio F,Gu WY.Quantitative analysis of exogenous IGF-1 administration of intervertebral disc through intradiscal injection [J].J Biomech,2012,45(7): 1149-1155.
[23]
Wu Y,Cisewski S,Sachs BL,et al.Effect of cartilage endplate on cell based disc regeneration: a finite element analysis[J].Mol Cell Biomech,2013,10(2): 159-182.
[24]
Xu HM,Hu F,Wang XY,et al.Relationship between apoptosis of endplate microvasculature and degeneration of the intervertebral disk[J].World Neurosurg,2019,125: e392-e397.
[25]
Corrêa-Oliveira R,Fachi JL,Vieira A,et al.Regulation of immune cell function by short-chain fatty acids[J].Clin Transl Immunology,2016,5(4): e73.
[26]
Yan J,Herzog JW,Tsang K,et al.Gut microbiota induce IGF-1 and promote bone formation and growth [J].Proc Natl Acad Sci U S A,2016,113(47): E7554-E7563.
[27]
Khan S,Jena G.The role of butyrate,a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention[J].Epigenomics,2015,7(4):669-680.
[28]
Fan Y,Pedersen O.Gut microbiota in human metabolic health and disease[J].Nature reviews Microbiology,2021,19(1): 55-71.
[29]
Wang F,Cai F,Shi R,et al.Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration[J].Osteoarthritis Cartilage,2016,24(3): 398-408.
[30]
Risbud MV,Shapiro IM.Role of cytokines in intervertebral disc degeneration: pain and disc content[J].Nat Rev Rheumatol,2014,10(1): 44-56.
[31]
De Luca P,De Girolamo L,Kouroupis D,et al.Intervertebral disc and endplate cells response to IL-1beta inflammatory cell priming and identification of molecular targets of tissue degeneration[J].Eur Cell Mater,2020,39:227-248.
[32]
Kumar M,Babaei P,Ji B,et al.Human gut microbiota and healthy aging: recent developments and future prospective[J].Nutr Healthy Aging,2016,4(1): 3-16.
[33]
Hodgkinson K,El Abbar F,Dobranowski P,et al.Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease[J].Clin Nutr,2023,42(2): 61-75.
[34]
Liu H,Wang J,He T,et al.Butyrate: a double-edged sword for health? [J].Adv Nutr,2018,9(1): 21-29.
[35]
Cani PD,Amar J, Iglesias MA, et al.Metabolic endotoxemia initiates obesity and insulin resistance[J].Diabetes,2007,56(7): 1761-1772.
[36]
Mohammad S,Thiemermann C.Role of metabolic endotoxemia in systemic inflammation and potential interventions [J].Front Immunol,2020,11: 594150.
[37]
Lyu FJ, Cui H, Pan H, et al.Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions [J].Bone Res,2021,9(1): 7.
[38]
Perry A,Lambert P.Propionibacterium acnes: infection beyond the skin[J].Expert Rev Anti Infect Ther,2011,9(12): 1149-1156.
[39]
Stirling A,Worthington T,Rafiq M,et al.Association between sciatica and propionibacterium acnes[J].Lancet,2001,357(9273): 2024-2025.
[40]
Jiao Y,Yuan Y,Lin Y,et al.Propionibacterium acnes induces discogenic low back pain via stimulating nucleus pulposus cells to secrete pro-algesic factor of IL-8/CINC-1 through TLR2-NF-κB p65 pathway[J].J Mol Med (Berl),2019,97(1): 25-35
[41]
Jiao Y,Lin Y,Zheng J,et al.Propionibacterium acnes contributes to low back pain via upregulation of NGF in TLR2-NF-κB/JNK or ROS pathway[J].Microbes Infect,2022,24(6-7): 104980.
[42]
Xu HW,Yi YY,Zhang SB,et al.Does vitamin D status influence lumbar disc degeneration and low back pain in postmenopausal women? A retrospective single-center study[J].Menopause,2020,27(5): 586-592.
[43]
Pai MV.Osteoporosis prevention and management[J].J Obstet Gynaecol,2017,67(4): 237-242.
[44]
Mackiewicz Z,Salo J,Konttinen YT,et al.Receptor activator of nuclear factor kappa B ligand in an experimental intervertebral disc degeneration[J].Clin Exp Rheumatol,2009,27(2): 299-306.
[45]
Rutges JP,Duit RA,Kummer JA,et al.Hypertrophic differentiation and calcification during intervertebral disc degeneration [J].Osteoarthritis Cartilage,2010,18(11):1487-1495.
[46]
Weaver CM.Diet,gut microbiome,and bone health[J].Curr Osteoporos Rep,2015,13(2): 125-130.
[47]
Zaiss MM,Axmann R, Zwerina J, et al.Treg cells suppress osteoclast formation: a new link between the immune system and bone[J].Arthritis Rheum,2007,56(12): 4104-4112.
[48]
Yuan FL,Li X,Lu WG,et al.Regulatory T cells as a potent target for controlling bone loss[J].Biochem Biophys Res Commun,2010,402(2):173-176.
[49]
Sato K,Suematsu A,Okamoto K,et al.Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction[J].J Exp Med,2006,203(12): 2673-2682.
[50]
Li JY,Yu M,Pal S,et al.Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota[J].J Clin Invest,2020,130(4): 1767-1781.
[1] 蒲彦婷, 吴翠先, 兰玉梅. 类风湿关节炎患者骨质疏松症风险预测列线图模型构建[J]. 中华关节外科杂志(电子版), 2024, 18(05): 596-603.
[2] 郑永乐, 庞祖才, 陈家敏, 孙丙银. 骨碎补总黄酮抑制牵张成骨模型骨质疏松的作用研究[J]. 中华关节外科杂志(电子版), 2024, 18(05): 604-608.
[3] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[4] 杨瑾, 刘雪克, 张媛媛, 金钧, 韦瑶. 肠道微生物来源石胆酸对脓毒症相关肝损伤的保护作用[J]. 中华危重症医学杂志(电子版), 2024, 17(04): 265-274.
[5] 李争光, 宰爽嘉, 吴火峰, 孙华, 张永博, 陈浏阳, 戴睿, 张亮. 昼夜节律相关因子在椎间盘退行性变发病机制中作用的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(05): 457-461.
[6] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[7] 方道成, 唐春华, 胡媛媛. 肠道菌群对草酸钙肾结石形成的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 509-513.
[8] 张龙, 孙善柯, 徐伟, 李文柱, 李俊达, 池涌泉, 何广胜, 成峰, 王学浩, 饶建华. 腹腔镜脾切除治疗血液系统疾病的临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 870-875.
[9] 王天福, 王刚. 自身免疫性胰腺炎诊治现状[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 492-497.
[10] 周锐, 罗飞. 骨质疏松椎体骨折的分型进展[J]. 中华老年骨科与康复电子杂志, 2024, 10(05): 315-320.
[11] 冯献礼, 高彤, 张喜善. 骨水泥注射量及弥散程度与PVP治疗OVCF的疗效分析[J]. 中华老年骨科与康复电子杂志, 2024, 10(04): 193-201.
[12] 李彦霖, 王海程, 权元元, 张一凡, 陈伟. 腰椎骨小梁生物力学特性及其在骨质疏松骨折治疗中的应用[J]. 中华老年骨科与康复电子杂志, 2024, 10(04): 243-250.
[13] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
[14] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[15] 赵小民, 杨军, 田巍巍. 枳术颗粒联合利那洛肽治疗便秘型肠易激综合征的临床研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 465-469.
阅读次数
全文


摘要